Companies / Oncolytics Biotech Inc

Oncolytics Biotech Inc

Nasdaq: ONCYCIK 1129928SAN DIEGO, CAoncolyticsbiotech.com

Financials

Revenue
Net income$-28.76M
Total debt
Cash$4.12M
Diluted EPS$-0.30
Shares outstanding127.5M

Ownership

127.5M shares outstanding · as of Aug 10, 2026
1.7%Insiders
Ownership
Insiders1.68%2,143,775
Institutions0.76%971,708
Public float97.56%124,395,022

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
0.44%566,991
Pisano WayneDirector
0.39%492,414
Look KirkChief Financial Officer
0.23%287,515
Heineman Thomas CharlesChief Medical Officer
0.22%282,818
Hagerman AllisonChief Technology Officer
0.09%115,059
Kelly JaredCEOChief Executive Officer · Director
0.09%114,050
0.09%109,851
0.06%78,128
Aromando AndrewChief Business Officer
0.04%55,100
0.03%41,849

Institutional holders 5

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 16, 2026Seizinger Bernd R.
Director
BuyCommon Shares$103.8K+100K
+27.25%
466,991
0.37% of shares
medium
Feb 11, 2026Seizinger Bernd R.
Director
BuyCommon Shares$49.6K+60K
+12.85%
526,991
0.41% of shares
low
Feb 12, 2026Seizinger Bernd R.
Director
BuyCommon Shares$33.9K+40K
+7.59%
566,991
0.44% of shares
low
Feb 12, 2026Andrews Patricia S
Director
BuyCommon Shares$30.3K+35K
+82.85%
78,128
0.06% of shares
low
Feb 11, 2026Aromando Andrew
Executive
BuyCommon Shares$25.4K+30K
+116.08%
55,100
0.04% of shares
low
Feb 12, 2026Pisano Wayne
Director
BuyCommon Shares$25.3K+30K
+6.49%
492,414
0.39% of shares
low
Feb 12, 2026Kelly Jared
CEO
BuyCommon Shares$24.8K+30K
+37.11%
109,000
0.09% of shares
low
Feb 12, 2026Brown Deborah Margaret
Director
BuyCommon Shares$21.2K+25K
+29.46%
109,851
0.09% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ONCYCommon StockEquity68237V103BBG000DVS826